Get the Stockscreener App
12.91
0.86%
0.11
After Hours:
12.78
-0.13
-1.01%
Atara Biotherapeutics Inc stock is traded at $12.91, with a volume of 65,654.
It is up +0.86% in the last 24 hours and up +15.06% over the past month.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
See More
Previous Close:
$12.80
Open:
$12.78
24h Volume:
65,654
Relative Volume:
1.25
Market Cap:
$90.67M
Revenue:
$100.44M
Net Income/Loss:
$-133.16M
P/E Ratio:
-0.5012
EPS:
-25.76
Net Cash Flow:
$-94.85M
1W Performance:
+7.14%
1M Performance:
+15.06%
6M Performance:
+76.61%
1Y Performance:
+29.10%
1-Day Range:
$12.41
$13.20
1-Week Range:
$11.81
$13.20
52-Week Range:
$5.005
$18.70
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
Name
Atara Biotherapeutics Inc
Sector
Industry
Phone
805-623-4211
Address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Compare ATRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
12.91 | 89.89M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-09-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-09-23 | Downgrade | Mizuho | Buy → Neutral |
| Jul-20-22 | Downgrade | Citigroup | Neutral → Sell |
| Jul-13-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-22 | Downgrade | Stifel | Buy → Hold |
| May-10-22 | Downgrade | Citigroup | Buy → Neutral |
| May-13-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-09-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-08-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-10-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Initiated | Evercore ISI | Outperform |
| Jun-15-20 | Initiated | H.C. Wainwright | Buy |
| Apr-23-20 | Upgrade | Citigroup | Neutral → Buy |
| Nov-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-19 | Downgrade | Goldman | Neutral → Sell |
| Sep-16-19 | Downgrade | Jefferies | Buy → Hold |
| Jun-04-19 | Upgrade | Citigroup | Sell → Neutral |
| May-30-19 | Initiated | ROTH Capital | Buy |
| May-23-19 | Initiated | Stifel | Buy |
| Jan-23-19 | Initiated | Mizuho | Buy |
| Apr-10-18 | Initiated | JP Morgan | Overweight |
| Mar-16-18 | Initiated | Guggenheim | Neutral |
| Mar-05-18 | Reiterated | Jefferies | Buy |
| Feb-28-18 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Feb-15-18 | Downgrade | Citigroup | Neutral → Sell |
| Jan-03-18 | Upgrade | Citigroup | Sell → Neutral |
| Oct-06-17 | Resumed | Goldman | Neutral |
View All
Atara Biotherapeutics Inc Stock (ATRA) Latest News
Should you hold or exit Atara Biotherapeutics Inc. nowTrade Analysis Report & AI Enhanced Trading Signals - Newser
Will Atara Biotherapeutics Inc. stock go up soon2025 Year in Review & Fast Gain Stock Trading Tips - Newser
What is Atara Biotherapeutics Inc.’s market positionPortfolio Profit Report & Daily Growth Stock Tips - خودرو بانک
Is Atara Biotherapeutics Inc. part of any ETFJuly 2025 Update & Real-Time Price Movement Reports - خودرو بانک
Historical volatility pattern of Atara Biotherapeutics Inc. visualizedRate Cut & Fast Gain Swing Trade Alerts - Newser
Will Atara Biotherapeutics Inc. benefit from government policyJuly 2025 Price Swings & Stepwise Swing Trade Plans - خودرو بانک
Analyzing Atara Biotherapeutics Inc. with risk reward ratio chartsRecession Risk & Verified Entry Point Detection - Newser
Using fundamentals and technicals on Atara Biotherapeutics IncJuly 2025 Review & Technical Pattern Alert System - Newser
Published on: 2025-09-05 14:22:04 - Newser
Can Atara Biotherapeutics Inc. recover in the next quarterBuy Signal & Free Community Supported Trade Ideas - Newser
How to manage a losing position in Atara Biotherapeutics Inc.July 2025 Recap & High Accuracy Investment Entry Signals - Newser
Technical signs of recovery in Atara Biotherapeutics Inc.Market Performance Recap & Fast Exit and Entry Strategy Plans - Newser
Leading vs lagging indicators on Atara Biotherapeutics Inc. performancePortfolio Risk Summary & Safe Swing Trade Setup Alerts - Newser
Market reaction to Atara Biotherapeutics Inc.’s recent newsWeekly Trade Recap & Weekly Breakout Watchlists - Newser
Published on: 2025-09-04 21:50:54 - Newser
Using data tools to time your Atara Biotherapeutics Inc. exit2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
Atara Biotherapeutics Inc. stock daily chart insights2025 Price Action Summary & Weekly Consistent Profit Watchlists - Newser
Using Ichimoku Cloud for Atara Biotherapeutics Inc. technicalsJuly 2025 Outlook & Technical Pattern Alert System - Newser
What’s the recovery path for long term holders of Atara Biotherapeutics Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Atara Biotherapeutics Reduces Board Size, Appoints New Chair - TipRanks
Candlestick signals on Atara Biotherapeutics Inc. stock today2025 Major Catalysts & Real-Time Volume Spike Alerts - Newser
Is Atara Biotherapeutics Inc. showing insider buying2025 Volume Leaders & Momentum Based Trading Ideas - خودرو بانک
Atara Biotherapeutics Inc. recovery potential after sell off2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Using portfolio simulators with Atara Biotherapeutics Inc. includedMarket Growth Review & Safe Swing Trade Setups - Newser
Building trade automation scripts for Atara Biotherapeutics Inc.July 2025 Market Mood & Weekly Momentum Picks - Newser
What MACD signals say about Atara Biotherapeutics Inc.July 2025 Snapshot & Free Technical Pattern Based Buy Signals - Newser
Chart based analysis of Atara Biotherapeutics Inc. trendsTrade Ideas & Fast Moving Stock Watchlists - Newser
Greg Ciongoli appointed as new chair of Atara Biotherapeutics board - Investing.com
Greg Ciongoli appointed as new chair of Atara Biotherapeutics board By Investing.com - Investing.com UK
Atara Biotherapeutics Announces Changes to Its Board of Directors - Business Wire
Published on: 2025-09-03 12:24:36 - Newser
Trend analysis for Atara Biotherapeutics Inc. this week2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
Is now a turning point for Atara Biotherapeutics Inc.2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Evaluating Atara Biotherapeutics Inc. with trendline analysis2025 Volume Leaders & Safe Capital Growth Trade Ideas - Newser
Will breakout in Atara Biotherapeutics Inc. lead to full recoveryLayoff News & Weekly Top Stock Performers List - Newser
Published on: 2025-09-03 04:06:27 - Newser
Does Atara Biotherapeutics Inc. have declining or rising EPS2025 Market Sentiment & Free Accurate Trade Setup Notifications - خودرو بانک
Key metrics from Atara Biotherapeutics Inc.’s quarterly dataWeekly Earnings Recap & Safe Entry Point Identification - Newser
Should I invest in Atara Biotherapeutics Inc. before earnings2025 Market Sentiment & AI Forecast for Swing Trade Picks - خودرو بانک
Published on: 2025-09-02 14:34:30 - Newser
Can Atara Biotherapeutics Inc. stock double in the next yearInflation Watch & Stock Timing and Entry Methods - خودرو بانک
How to read the order book for Atara Biotherapeutics Inc.2025 Fundamental Recap & AI Driven Stock Reports - Newser
Atara Biotherapeutics Inc Stock (ATRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):